Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease
Clinical trial NCT04780399 · UNKNOWN
Trial details
- NCT number
- NCT04780399
- Sponsor
- Dongzhimen Hospital, Beijing
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-09
- Primary completion
- 2024-03-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.